Screener
AngioDynamics ANGO International — Net Sales
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by AngioDynamics in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: AngioDynamics’s 10-K, filed July 14, 2026.
- Filed
- Jul 14, 2026, 3:42 PM EDT
- Fiscal year
- FY2026
- Accession
- 0001628280-26-048138
| (in thousands) | Year ended May 31, 2026 / United States | Year ended May 31, 2026 / International | Year ended May 31, 2026 / Total | Year ended May 31, 2025 / United States | Year ended May 31, 2025 / International | Year ended May 31, 2025 / Total |
|---|---|---|---|---|---|---|
| Net sales | ||||||
| Med Tech | $129,830 | $20,124 | $149,954 | $109,254 | $17,399 | $126,653 |
| Med Device | 145,093 | 25,127 | 170,220 | 141,729 | 24,116 | 165,845 |
| Total | $274,923 | $45,251 | $320,174 | $250,983 | $41,515 | $292,498 |
Item 15. Exhibits, Financial Statement Schedules.
FAQ
- What is AngioDynamics's international — net sales?
- AngioDynamics (ANGO) reported international — net sales of $13.01M in Q1 2026.
- How has AngioDynamics's international — net sales changed year-over-year?
- AngioDynamics's international — net sales increased by 2.7% year-over-year, from $12.67M to $13.01M.
- What is the long-term trend for AngioDynamics's international — net sales?
- Over 4 years (2022 to 2026), AngioDynamics's international — net sales has grown at a -2.6% compound annual growth rate (CAGR), from $50.26M to $45.25M.
- What does international — net sales mean?
- This metric represents the total revenue generated from the sale of medical devices and therapeutic solutions within international markets, excluding the domestic home market. It serves as a key indicator of the company's global footprint and its ability to successfully commercialize its peripheral vascular and oncology product portfolios outside of its primary region. Monitoring this figure helps investors assess the company's international market penetration and growth strategy.
Ask your AI about AngioDynamics's international — net sales.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude